CD27 and neoplasm: The higher expression of CD27 was a favorable prognostic marker and associated with good survival outcomes in multiple cancers like CESC, HNSC, LIHC and SKCM after adjusting for the abundances of tumor infiltrating immune cells (Fig. 4, Figs S7 and S11).